Lisa Haddad is a partner in the firm’s Public M&A / Corporate Governance practice. She focuses on mergers and acquisitions involving public companies and corporate governance matters. Lisa serves on the firm’s Allocations Committee. She was formerly a member of the firm’s Executive Committee, co-chair of the Public M&A / Corporate Governance practice, and co-chair of Goodwin’s Women’s Initiative.
Lisa has extensive experience in representing buyers, sellers and financial advisors in merger and acquisition transactions involving both public and private companies, especially in the life sciences and technology sectors. In this area, she has a special focus on public company mergers and acquisitions, spin-offs, and other complex transactions involving public companies.
Representative Matters
Professional Activities
Lisa is a member of the Massachusetts and Boston Bar Associations.
Credentials
Education
JD1996
Harvard Law School
(magna cum laude)
BBA1993
University of Massachusetts Amherst
(cum laude)
Admissions
Bars
- Massachusetts
Recognition & Awards
Lisa has been recognized by:
- Chambers USA 2021-2025 for her work in Corporate/M&A
- Lawdragon 500 Leading Dealmakers in America for 2025
- Ranked #3 Woman Dealmaker in MergerLinks’ Top M&A Deal Leads for 2024 ($38B)
- The Best Lawyers in America since 2023
- The American Lawyer as a 2023 Dealmaker of the Year (along with Stuart Cable)
- The Deal’s Top Women in Dealmaking for 2022
- The American Lawyer as a 2022 Northeast Trailblazer
- BTI Consulting Group as a 2022 BTI Client Service All-Star
- The Legal 500 as a 2021 recommended lawyer for Corporate Governance and Shareholder Activism: Advice to Boards
Lisa also was recognized by the Financial Times with its award for Innovative Deal of the Year in 2015 for advising Foundation Medicine in its $1.0 billion majority purchase by Roche, and in 2016 for advising Citrix Systems in its $2.9 billion Reverse Morris Trust transaction with LogMeIn.
Publications
Lisa is a co-director of Goodwin’s Annual Directors Forum, an educational program designed for directors of public companies, and GOOD Directors, a leadership program focused on the next generation of public company directors. She also speaks at various board education programs and legal seminars on topics in her areas of practice.